Algorithm, Iroko, Fahrenheit deal

Iroko granted Algorithm exclusive rights to develop and commercialize Zorvolex submicron diclofenac in the Middle East and North Africa (MENA) region. Separately, Iroko granted Fahrenheit exclusive r...